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Abstract
Background: The ImmunoCAP ISAC 112 is a fluoro-immunoassay that allows detection of specific IgE to 112 molecular
components from 51 allergenic sources. We studied the reliability of this technique intra- and inter- assay, as well as inter-
batch- and inter-laboratory-assay.
Methods: Twenty samples were studied, nineteen sera from polysensitized allergic patients, and the technique calibrator
provided by the manufacturer (CTR02). We measured the sIgE from CTR02 and three patients’ sera ten times in the same
and in different assays. Furthermore, all samples were tested in two laboratories and with two batches of ISAC kit. To
evaluate the accuracy of ISAC 112, we contrasted the determinations of CTR02 calibrator with their expected values by T
Student test. To analyse the precision, we calculated the coefficient of variation (CV) of the 15 allergens that generate the
calibration curve, and to analyse the repeatability and the reproducibility, we calculated the intraclass coefficient correlation
(ICC) to each allergen.
Results: The results obtained for CTR02 were similar to those expected in 7 of 15 allergens that generate the calibration
curve, whereas in 8 allergens the results showed significant differences. The mean CV obtained in the CTR02 determinations
was of 9.4%, and the variability of sera from patients was of 22.9%. The agreement in the intra- and inter-assay analysis was
very good to 94 allergens and good to one. In the inter-batch analyse, we obtained a very good agreement to 82 allergens,
good to 14, moderate to 5 allergens, poor to one, and bad to 1 allergen. In the inter-laboratory analyse, we obtained a very
good agreement to 73 allergens, good to 22, moderate to 6 and poor to two allergens.
Conclusion: The allergen microarray immunoassay, ISAC 112, is a repeatable and reproducible in vitro diagnostic tool for
determination of sIgE beyond the own laboratory.
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Introduction
Component-based allergological diagnosis has opened up a new
era in the study of allergies. It allows the identification of specific
sensitization against proteins or specific molecular components [1–
4]. This new approach helps to clarify the molecular bases of
primary sensitization and cross-reactivity phenomena [5–11]. It
also helps to rationalize the indication for immunotherapy based
on the administration of allergenic components [12–14] and
constitutes a necessary tool in the choice of a diet free from
allergens in food-allergic patients [12,15].
The technique of the commercially available protein microarray
ImmunoCAP ISACH specific IgE (sIgE) 112 offers the possibility
of analyzing sIgE against 112 components of purified natural
proteins and recombinant proteins from 51 different allergenic
sources. Since its launch onto the market, this platform has
generated great expectations [16–19], and its use is being
introduced into clinical practice because, at least from the
conceptual point of view, it could be an aid to the clinician in
the diagnosis or treatment indication of certain patients, especially
those polysensitized ones [6,20]. However, clinical and technical
validations and comparative studies are still needed [21–23]. In
fact, previous version of this platform (ISAC 103) showed high
variability for certain allergens [21], and even low efficiency in
diagnosing sensitizations to certain proteins [24]. Thus, data
assessing reliability of this technique, now for version ISAC 112,
are required even beyond each laboratory.
The objective of this study was to assess the accuracy, precision,
repeatability and reproducibility of this platform. To this aim we
carried out assays with the technique’s calibrating sample and sera
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from polysensitized patients under different conditions including
determinations performed both in the same assay and in different
assays and considering as possible sources of additional variability
the use of different batches of reagents and the performance of the
technique in different laboratories.
Materials and Methods
Samples
A total of 20 samples were analyzed: the calibrator sample
(CTR02), provided by the manufacturer and 19 sera from
polysensitized patients. The research ethical committee from the
Universidad de Navarra approved the study ‘‘Technical and
clinical validation of the diagnostic capacity of microarrays of
allergenic molecules in allergy to pollens and/or vegetable foods’’
in which this work has been done. Patients provided their written
informed consent to participate in this study. After inclusion for
this work, the data from the patients’ sera were analyzed
anonymously.
The CTR02 calibrator, according to information provided by
the manufacturer, is composed of known amounts of chimeric
monoclonal antibodies humanized against 15 molecular compo-
nents (Amb a 1, Art v 1, Bet v 1, Can f 1, Can f 2, Can f 5, Der p 1,
Der p 2, Fel d 1, Gal d 1, Gal d 2, Ole e 1, Phl p 1, Phl p 5, and
Pru p 3). The antibodies against these 15 allergenic components
are found in the calibrator in a range of 4 different concentrations
expressed in ISAC Standardized Units (ISU) values for sIgE (1, 4,
15 and 50 ISU). This allows a calibration curve to be plotted from
the 4 points of fluorescence intensity corresponding to the different
ISU (figure 1).
Of the 19 sera from the polysensitized patients, sera 1, 2, and 3,
contained as a group detectable amounts of sIgE against the 15
allergens making up the calibration curve and against another 80
allergens (of the 112 represented in the microarray). Sixteen
additional sera, numbered 4–19, showing a broad variety of
sensitizations were also included in the study.
Patients’ sera were frozen at 220uC after the blood collection
until the immunoassays were performed and, among the different
assays, samples were conserved at 4uC.
InmunoCAP ISAC 112 microarray
The microarray ISAC 112 (ThermoFisher, Uppsala, Sweden) is
a solid phase fluoro immunoassay that detects IgE antibodies
against the proteins fixed on ISAC surface. One slide contains 4
microarray and one kit 5 slides, 20 microarrays in total. The
technique was performed following the manufacturer’s instruc-
tions. Each microarray is incubated with a serum in order to label
sIgE to each protein and subsequently it is incubated with a
human anti IgE detection antibody conjugated with fluorescence.
Finally the fluorescence intensity of each microarray is
measured by the scanner (LuxScan 10K/A, CapitalBio, Beijing,
China) using following parameters: laser power (LP = 60) and
photo-multiplier tube (PMT = 600).
The analysis of the digitalized images is performed with the
software Phadia Microarray Image Analyzer (ThermoFisher). This
software allows transforming the images fluorescence intensity in
numerical data according to the calibration curve built with the
calibrator CTR02 sample included in each assay, as previously
described (figure 1). An acceptable calibration curve needs to show
slope parameters (Y) between 5.5 and 6.8, and R2.0.85 according
to the information provided by ThermoFisher.
The sIgE values are expressed semiquantitatively as ISU.
Results equal or greater than 0.30 ISU are considered positive,
according to the indications of the manufacturer.
Intra-assay analysis
The repeatability of the ISAC 112 technique was assessed by
analyzing the sIgE from the CTR02 calibrator and sera 1 to 3
obtained in 10 determinations performed in the same assay with 2
ISAC 112 kits from the same production batch. The calibration
curve was obtained with the first determination of the CTR02
calibrator in the first kit in the first slide, first microarray.
Inter-assay analysis
The reproducibility of the technique was assessed by analyzing
the sIgE results from the CTR02 calibrator and sera 1 to 3
obtained in 10 assays performed on 10 different days using 2 ISAC
112 kits from the same production batch. For each assay a
calibration curve was plotted with the calibration curve performed
in its own assay.
Inter-laboratory analysis
The reproducibility of the ISAC 112 technique was assessed by
analyzing the levels of sIgE obtained from the 20 samples studied
with 2 kits from the same batch. The analyses were performed in
two different laboratories i.e.: Clı´nica Universidad de Navarra,
and the Complejo Hospitalario de Navarra, both in Pamplona,
Navarra, Spain. The reading of the chips was performed with the
same conditions in each laboratory. The calibration curve was
plotted with the determination of the CTR02 calibrator performed
Figure 1. Calibration curve. Example of calibration curve used for
the intra-assay analysis.
doi:10.1371/journal.pone.0088394.g001
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in each laboratory. Both scanners had been calibrated similarly by
the same technician, the same day.
Inter-batch analysis
The reproducibility of the ISAC 112 technique was also
assessed by analyzing sIgE levels from the 20 samples under study
obtained from two kits from different production batch.
Statistical analysis of the data
We studied the accuracy of ISAC 112, understood as the
similarity between the values obtained and those expected, and its
precision, understood as the dispersion of the group of results
obtained.
We evaluated the accuracy by the analysis of the determinations
performed in all the assays with the sample CTR02, after
comparison of the results expected and those obtained for each
one of the 15 allergens that constitute the calibration curve by
means of the Student’s T test.
Furthermore, the precision of the allergens from the calibration
curve was analyzed by calculating the coefficient of variation (CV)
in all the assays, as the percentage of the standard deviation of the
determinations divided by the mean. We calculated the CV from
the results obtained from the CTR02 calibrator.
We analyzed the strength of agreement of the determinations
under the same conditions, repeatability, and different conditions,
reproducibility, of the results obtained in the different assays by
calculating the intraclass coefficient correlation (ICC) for each
allergen [25,26]. The level of agreement using the ICC was
expressed using the classification of Fleiss [27] as: very good
(ICC.0.90), good (0.71–0.90), moderate (0.51–070), mediocre
(0.31–0.50) or poor (ICC,0.30).
Also, we analysed the reliability of the semiquantitative character
of the technique comparing the number of allergens that modified
the category of the IgE according to the range established by the
manufacturer (,0.3 ISU, not detectable; $0.3–,1 ISU, low;$1–
,15 moderated or high; and $15, very high), in the interassay
determinations for each serum.
The Student’s T test and the ICC for each allergen were
performed using the statistical software package SPSS (Statistical
Packaged for social science) for Windows, version 15.0 (Chicago,
Illinois, USA). The CV was calculated using the program Excel
version 12.0, Microsoft Office 2007.
Results
Accuracy
The average values obtained in the sIgE determinations against
the allergens of the calibration curve Der p 2, Gal d 1, Ole e 1,
Can f 1, Can f 5, Phl p 5 and Pru p 3 by ISAC resulted to be
similar to those expected (figure 2). Nevertheless, the determina-
tions of the remaining 8 allergens showed statistically significant
differences (p,0.05) between the observed levels and those
expected. Of these 8 allergens, six allergens (Art v 1, Fel d 1,
Phl p 1, Amb a 1, Can f 1, Der p 1 and Gal d 2) are in the
intermediate points of the calibration curve (4 and 15 ISU),
whereas the Bet v 1 belongs to a 1 ISU calibration point and the
Figure 2. Accuracy of ISAC 112. Results obtained for the allergens
that form the calibration curve with the intra-assay, inter-assay, inter-
laboratory and inter-batch determinations performed with the calibra-
tor CTR02, composed by chimeric antibodies. Expected ISU results are
depicted by red line and the observed mean ISU results are depicted by
red +++. Student T test was used for statistical analysis.
doi:10.1371/journal.pone.0088394.g002
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Can f 2 belongs to the 50 ISU calibration point. Despite these
differences, all the calibrator CTR02 determinations gave place to
a calibration curve within the slope parameters and R2 considered
by the manufacturer as acceptable (Y and R2 maximum and
minimum obtained at the assays 6.52–5.8 and 0.99–0.95,
respectively)
Precision
When we analyzed the global variability in the results from the
different determinations of the CTR02 calibrator, we obtained a
mean CV of 9.42%.
The individual data of the calibrating sera allergens are
expressed in figure 3.
Repeatability and reproducibility
Repeatability and reproducibility calculated using the ICC are
summarised in table 1.
The analysis of the repeatability (intra-assay analysis) was very
good for 94 of the 112 allergens represented in the microarray and
good for the Bos d lactoferrin allergen. For the remaining 17
allergens the ICC could not be calculated as all the determinations
were equal to 0 ISU.
The analysis of the inter-assay reproducibility was very good for
94 of the 112 allergens and good for the Pol d 5 allergen.
The reproducibility between the analyses of the determinations
in two laboratories was very good for 73 allergens and good for 22
of the allergens represented in the microarray. The allergens Ara h
9, Art v 1, Bla g 5, Bos d 8, Bos d lactoferrin, and Phl p 12, showed
a moderate agreement whereas in Jug r 2 and Alt a 6 agreement
was mediocre. The ICC values could not be calculated for 9
allergens in inter-laboratories analysis because all the determina-
tions for them were equal to 0 ISU.
Finally, in the analysis of the reproducibility between the two
kits from different production batches we obtained a very good
agreement for 82 allergens and good for 14 allergens. For the
allergens Bos d 8, Lep d 2, Pen m 1, Ses i 1 and Ves v 5 we
obtained a moderate ICC while for Bos d lactoferrin and Alt a 6
gave a mediocre and poor agreement respectively. The ICC values
could not be calculated for 9 allergens in inter-batch analysis
because all the determinations for them were equal to 0 ISU.
Disagreements in the IgE level
When analysing the number of disagreements in the interassay
analysis determinations in patients’ sera, we obtained the following
results. The results of sIgE obtained modified from ‘‘not
detectable’’ level to ‘‘low’’ level for 7 allergens when analysing
sera 1 and 2, and for 9 allergens when analysing sera 3. The
specific IgE levels modified from ‘‘low’’ to ‘‘moderate-high’’ for 7
allergens when analysing sera 1 and 2, and for 13 when analysing
sera 3. The specific IgE level change from ‘‘moderate-high’’ to
‘‘very high’’ happened in 16 occasions when analysing sera 1, and
in 15 occasions when analysing sera 2. Finally, the IgE level
change from ‘‘not detectable’’ to ‘‘high’’ was observed for 4 and 5
allergens when using sera 1 and 2 respectively. This allergens were
Act d 1, Asp f 1, Ara h 8, Ber e 1, Cor a 9, Mal d 1, Phl p 5, Phl p
12 and Pla l 1. The allergens that showed a greater number of
disagreements were Jug r 2, Jug r 3 and Ses i 1, which had
disagreements on the IgE level in the three sera studied.
Discussion
The technique of protein microarrays has been accepted as a
useful method for the detection of sIgE against molecular
components [28,29]. Thus, it has been shown its usefulness for
the diagnosis of food allergies, to determine cross-reactivity
phenomena or sensitization patterns in specific geographical areas
[14,20]. Previously, several comparative studies between ISAC
and other conventional techniques of sIgE detection, such as
ImmunoCAP have been performed. These studies state that
although the results obtained between both methods are not
comparable, a good agreement between them was found
[13,20,30].
However, few studies have been carried out into the variability
and accuracy of this technique showing improvable results in
previous versions of this microarray [17,21]. In the present study,
we analyzed accuracy, variability and reproducibility in the new
version, ImmunoCAP ISAC 112. The results obtained in the study
show good reproducibility of the technique not only for one assay
but even considering changes of the assays in different days, and
using different batches and in different laboratories.
When analysing the accuracy of the technique, 8 of the 15
allergens that form the calibration curve showed statistically
significant differences between the values obtained and those
expected. Despite this fact, all the calibration lines were within
Figure 3. Variability of the ISAC 112 technique in the calibrator sample. Coefficient of Variation (CV) obtained to allergens of calibration
curve. The results are the mean CV of 10 determinations intra- and inter-assay, and 2 determinations inter-laboratory and inter-batches of the
calibrator sample.
doi:10.1371/journal.pone.0088394.g003
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Table 1. Intraclass Correlation Coefficient (ICC) of ISAC 112 results obtained from 10 determinations of 4 sera intra- and inter-assay
and two determinations of 20 sera inter-laboratory and inter-batch.
ALLERGEN INTRA-ASSAY INTER-ASSAY INTER-LAB INTER-BATCH ALLERGEN INTRA-ASSAY
INTER-
ASSAY INTER-LAB INTER-BATCH
Act d 1 0.983 0.978 0.950 0.995 Equ c 1 0.998 0.983 0.914 0.914
Act d 2 0.999 0.985 0.851 0.879 Equ c 3 0.999 0.996 0.948 0.954
Act d 5 0.978 0.955 0.834 * Fag e 2 0.998 0.980 0.986 0.996
Act d 8 0.987 0.848 0.907 0.970 Fel d 1 { 0.994 0.987 0.981 0.993
Aln g 1 0.977 0.956 0.867 0.707 Fel d 2 0.996 0.996 0.987 0.775
Alt a 1 0.999 0.993 0.897 0.878 Fel d 4 0.997 0.966 0.970 0.925
Alt a 6 0.988 0.977 0.497 0.267 Gad c 1 0.999 0.986 0.995 0.988
Amb a 1 { 0.996 0.994 0.981 0.900 Gal d 1 { 1.000 0.918 0.970 0.993
Ana o 2 0.998 0.986 0.945 * Gal d 2 { 0.998 0.969 0.987 0.986
Ani s 1 * 0.994 0.984 0.987 Gal d 3 1.000 0.993 0.998 0.999
Ani s 3 * * 0.988 0.998 Gal d 5 0.998 0.986 0.997 0.922
Api g 1 0.998 0.978 0.986 0.980 Gly m 4 0.998 0.983 0.998 0.961
Api m 1 * * 0.973 0.998 Gly m 5 0.997 0.990 0.838 0.944
Api m 4 * * * * Gly m 6 0.997 0.989 0.955 0.960
Ara h 1 0.997 0.990 0.979 0.963 Hev b 1 * * 0.945 *
Ara h 2 0.997 0.993 0.937 0.991 Hev b 3 * * 0.973 0.991
Ara h 3 * * 0.991 0.928 Hev b 5 1.000 0.995 0.998 0.997
Ara h 6 0.990 0.983 0.868 0.960 Hev b 6.01 0.993 * 0.990 0.995
Ara h 8 0.994 0.980 0.853 0.850 Hev b 8 1.000 0.997 0.999 0.997
Ara h 9 0.997 0.971 0.680 0.992 Jug r 1 0.996 0.986 0.880 0.974
Art v 1{ 1.000 0.996 0.703 0.997 Jug r 2 0.994 0.979 0.446 0.881
Art v 3 0.999 0.998 0.986 0.996 Jug r 3 0.999 0.984 0.921 0.983
Asp f 1 0.995 0.984 0.938 0.859 Lep d 2 0.999 0.977 0.941 0.697
Asp f 3 0.999 0.994 0.955 0.998 Mal d 1 0.998 0.994 0.992 0.998
Asp f 6 0.991 0.997 * * Mer a 1 1.000 0.996 0.991 0.984
Ber e 1 0.996 0.983 0.779 0.715 Mus m 1 0.992 0.994 0.813 0.997
Bet v 1{ 0.999 0.994 0.984 0.973 MUXF3 1.000 0.989 0.923 0.998
Bet v 2 0.999 0.992 0.951 0.946 Ole e 1{ 1.000 0.995 0.992 0.990
Bet v 4 0.998 0.990 0.885 0.846 Ole e 7 0.999 0.989 0.831 0.907
Bla g 1 * * * * Ole e 9 0.999 0.993 0.980 0.995
Bla g 2 * * * * Par j 2 0.998 0.985 0.998 0.996
Bla g 5 0.992 0.980 0.646 0.776 Pen m 1 * * 0.994 0.663
Bla g 7 * * 0.959 0.955 Pen m 2 * * * *
Blo t 5 * * 0.924 0.993 Pen m 4 0.999 0.995 0.911 0.973
Bos d 4 * * 0.998 0.969 Phl p 1{ 1.000 0.996 0.991 0.989
Bos d 5 0.998 0.995 0.882 0.883 Phl p 11 0.997 0.989 0.994 0.968
Bos d 6 0.999 0.986 0.988 0.983 Phl p 12 0.998 0.979 0.586 0.725
Bos d 8 0.996 0.966 0.566 0.670 Phl p 2 0.998 0.981 0.944 0.886
Bos d Lact 0.865 0.981 0.596 0.464 Phl p 4 0.997 0.993 0.891 0.969
Can f 1 { 0.998 0.993 0.973 0.983 Phl p 5{ 1.000 0.992 0.952 0.990
Can f 2 { 1.000 0.999 0.977 0.998 Phl p 6 0.993 0.974 0.829 0.920
Can f 3 0.919 0.981 0.994 0.991 Phl p 7 0.999 0.987 0.784 0.995
Can f 5 { 0.999 0.998 0.996 0.999 Pla a 1 1.000 0.991 0.839 0.818
Che a 1 0.999 0.989 0.940 0.944 Pla a 2 1.000 0.988 0.733 0.904
Cla h 8 * * * * Pla a 3 0.986 0.964 0.821 0.984
Cor a 1.0101 0.998 0.991 0.998 0.988 Pla l 1 0.990 0.933 0.951 0.994
Cor a 1.0401 0.992 0.984 0.986 0.993 Pol d 5 0.983 0.891 0.996 0.998
Cor a 8 0.999 0.988 0.931 0.990 Pru p 1 0.994 0.944 0.972 0.969
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acceptable limits of slope and R2 established by the technique’s
supplier. The fact that most allergens keep their category, even at
low sIgE levels, supports the reliability of the results offered by the
technique. Nevertheless, it should be highlighted that this is a
semiquantitative technique and the IgE levels close to the cut off
points between categories can fluctuate in different assays.
Regarding the technique’s precision, the results obtained show a
low variability when we analyse the determinations of the control
sample CTR02, which is under 10% in most allergens. Also, the
CV is similar both in the analysis performed in the same assay and
in those performed in different assays. It is worth noting that the
capacity of the allergen to attach itself to the surface of the ISAC
array is lower than in quantitative techniques such as Immuno-
CAP, in which the allergen is fixed under excess molarity
conditions. This fact could make more clear differences in the
allergen ability to bind to the microarray leading into differences
in variability of specific IgE binding. Differences in reliability of
some allergens from the microarray (like Amb a 1, Der p 1 or Der
p 2) and considering that ISAC microarray is a semiquantitative
technique suggest that ISAC 112 is not the best method to monitor
sensitizations and patient’s follow-up.
However, in our opinion these analyses demonstrated an
evident improvement in the new version of the ISAC microarray.
This improvement can be, among others, due to the calibration
curve consisting in chimeric antibodies (sIgE) in contrast to the
serum with known sIgE concentration from previous versions
ISAC 103 [21]. This might be due to a good characterization of
chimeric antibodies and the absence of other isotypes able to bind
to the spotted allergens.
Finally, we studied the repeatability and reproducibility of the
technique, analysing the ICC in the different assays. The results
obtained in the intra-assay analysis show a good repeatability,
obtaining good agreement strength for almost all the allergens
present in microarray. Also, the reproducibility of the interassay
analysis showed good concordance strength for these allergens.
The reproducibility in the inter-laboratory and inter-batch analysis
still has good agreement strength for most allergens. Nevertheless,
this agreement strength was lower for 8 allergens in the inter-
laboratory analysis and for 7 allergens in the inter-batch
agreement. This slight decrease in the results’ agreement strength
could be due to the fact that only two determinations were
performed in each analysis instead of 10 repetitions like in the
interassay analysis. Also, the performance of analysis in different
laboratories and with different batches means a greater source of
variability.
In conclusion, ISAC 112 yields good reliability results taking
into account that ISAC 112 gives semi-quantitative results.
However, due to the low accuracy obtained in some of the
studied allergens, the application of this semi-quantitative tech-
nique for diagnosis in clinical situations where results may have a
major impact on the therapy prescribed may not be advisable.
Even more, this study suggests that neither laboratory specific
condition neither the change from one batch to another affect
substantially microarray reliability.
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